Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib

Epigenetic aging upon allogeneic transplantation: the hematopoietic niche does not affect age-associated DNA methylation

(2014) C I Weidner et al.   LEUKEMIA

Direct Comparison of Flow-FISH and qPCR as Diagnostic Tests for Telomere Length Measurement in Humans

(2014) Fernanda Gutierrez-Rodrigues et al.   PLoS One

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

(2013) M. Baccarani et al.   BLOOD

Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation

(2012) Patrick Ziegler et al.   ANNALS OF HEMATOLOGY

The telomere syndromes

(2012) Mary Armanios et al.   NATURE REVIEWS GENETICS

Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy

(2009) Gunhild Keller et al.   HEMATOLOGICAL ONCOLOGY